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Dietary Canola Oil Suppressed Growth of Implanted 
MDA-MB 231Human Breast Tumors in Nude Mice 
 
W. Elaine Hardman 
 
Abstract: Long chain omega 3 (n-3) fatty acids, eicosapentaenoic (EPA) and/or docosahexaen-
oic acid (DHA), have been shown to suppress growth of most cancer cells. In vivo, alpha lino-
lenic acid (ALA, 18:3n-3) can be converted to EPA or DHA. We hypothesized that substituting 
canola oil (10% ALA) for the corn oil (1% ALA) in the diet of cancer bearing mice would slow 
tumor growth by increasing n-3 fatty acids in the diet. Sixty nude mice received MDA-MB 231 
human breast cancer cells and were fed a diet containing 8% w/w corn oil until the mean tumor 
volume was 60 mm3. The dietary fat of half of the tumor bearing mice was then changed to 8% 
w/w canola oil. Compared to mice that consumed the corn oil containing diet, the mice that 
consumed the canola oil containing diet had significantly more EPA and DHA in both tumors 
and livers, and the mean tumor growth rate and cell proliferation in the tumor were significantly 
slower (P < 0.05). About 25 days after diet change, mice that consumed the corn oil diet stopped 
gaining weight, whereas the mice that consumed the canola oil diet continued normal weight 
gain. Use of canola oil instead of corn oil in the diet may be a reasonable means to increase 
consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer 
cells in cancer survivors. 
 
Introduction 
   
Supplementing the diet of cancer bearing mice with fish oil has been shown to reduce the 
growth rate of multiple tumor types and to increase the efficacy of various cancer chemotherap-
ies (briefly reviewed in [1]). Fish oil is high in long chain (20 and 22 carbons) omega 3 polyun-
saturated fatty acids. Testing of individual fatty acids in cell culture indicates that overall the 
eicosapentaenoic (EPA, 20:5n-3) and/or docosahexaenoic (DHA 22:6n-3) fractions of fish oil are 
the fractions of fish oil that are directly active for suppressing cancer cell growth via multiple 
mechanisms (1). 
The double bond at the omega 3 position is generated in plants but not in fish or mam-
mals. The alpha linolenic acid (ALA, 18:3n-3) that is consumed by fish from plant or algae 
sources is desaturated and elongated to EPA and DHA for incorporation into cell membranes of 
fish. Thus, even though oils derived from fish are high in EPA and DHA, plant derived dietary 
ALA was the source of these longer chain fatty acids.  
Humans and mice are also capable of desaturating and elongating 18 carbon fatty acids, 
of either the n-6 or n-3 derivation, to 20 or 22 carbon fatty acids. Linoleic acid (LA 18:3n-6) is 
converted to arachidonic acid (AA, 20:4n-6), whereas ALA is converted to EPA, 
docosapentaenoic (DPA, 22:5n-3), and DHA. The efficiency of conversion of ALA to longer 
chain fatty acids is varying and not completely known; however, there is some evidence that 
conversion of ALA to longer chain fatty acids in humans may be more efficient than previously 
thought (2). We hypothesized that incorporating ALA in the diet of mice, at levels that humans 
might reasonably consume would be beneficial for slowing the growth of an implanted cancer. 
In dietary studies, it seems important to use a source of ALA that could be used routinely 
in the diets of humans. Flaxseed oil (linseed oil) contains 50 to 60% ALA and about 15 to 20% 
linoleic acid, is an excellent source of ALA and consumption of flaxseed has been shown to slow 
growth of cancers implanted in mice (3). However, flaxseed oil is expensive (in the range of $15 
per liter), is not readily available in grocery stores, has a somewhat bitter taste, and is not recom-
mended for cooking uses. Canola oil (rapeseed oil) costs about the same as corn oil (about $2 per 
liter), is readily available in grocery stores, and can be used in cooking, baking, and salad dress-
ings. It contains about 10% ALA and 20% LA, not nearly as much ALA as flaxseed, oil, but 
could be a realistic, cost-effective means of increasing of omega 3 fatty acids in the human diet. 
Since corn oil contains 55 to 60% LA and less than 1% ALA, the routine use of canola oil 
instead of corn oil would improve the omega 6 to omega 3 ratio in the diet. 
This study was designed to determine whether removing corn oil and substituting with 
canola oil in the diet would provide the cancer growth suppressive benefits linked to long chain 
omega 3 fatty acids. 
 
Table 1. Diet Composition 
 
g/kg Diet   % of Total Energy   kcal/kg1 Dry Weight   Energy J/g2 Dry wt 
_____________________________________________________________________________________________________________________ 
 
Casein       200       19.3        716    3.00 
Sucrose      470       45.3                      1682.6     7.05 
Corn starch      150        14.5        540     2.26 
Alphacel         50          0            0     0 
Choline bitartrate          2.0          0            0     0 
DL-methionine          3.0          0            0     0 
AIN-76 mineral mix        35.0         0.4          16.5     0.07 
AIN-76A vitamin mix      10.0          1.0          39.2     0.16 
Either corn or canola oil   80.0        19.4        720    3.01 
Totals          99.9      3714.3                    15.55 
 
1Caloric density calculated from values supplied on Dyets, Inc., website: http://dyets.com/caloric.htm. 
2Calculated 1kcal/g = 4.187 J/g. 
 
Methods and Materials 
 
 
Preparation of Cells for Injection 
 
Cultured MDA-MB 231 cells (American Type Culture Collection, Rockville, MD) were 
harvested, rinsed, then suspended in serum-free, antibiotic-free L-15 base culture medium 
(American Type Culture Collection, Rockville, MD). Cells in suspension were counted using a 
hemocytometer, and the cell count was adjusted to 20 × 106/ml. The suspension was kept well 
mixed during the time of injection. MDA-MB 231 cells (1 × 106 cells in 0.05 ml of serum free 
media) were injected sc between the scapulae of each mouse. 
 
 
Dietary Fats 
 
Corn oil contains about 60% linoleic acid, 23% oleic acid, and 10% C16 fatty acids (>6 
mg/g n-3 PUFAs). The composition of the canola oil is about 20% linoleic acid, 10% alpha 
lenolenic acid, and 50% oleic acid. Both corn oil and canola oil were obtained at a local grocery 
store and were without added antioxidant. Opened bottles of oil were stored at 4◦C. 
 
 
Animals and Diet 
 
Sixty female athymic nu/nu mice (Harlan Sprague Dawley, Inc., Madison, WI), 3 mo old, 
received tumor cells. The mice were housed 4/box under aseptic conditions in a temperature 
(24◦C) and light-controlled (12 h/day) room. All animal use and handling was approved by the 
Pennington Biomedical Research Center Institutional Animal Care and Use Committee. 
The compositions of the diets are given in Table 1. All mice were fed the AIN-76A 
semipurified diet modified to contain 8% w/w corn oil from receipt until 3 wk after injection 
of cells to allow the tumors to become established. Forty-eight nude mice bearing growing 
MDA-MB-231 human breast carcinoma xenografts were then divided into 2 dietary groups such 
that the mean tumor size was not different between groups. Twenty-four mice were placed on the 
AIN-76A diet modified to contain 8% w/w canola oil. Diets were prepared monthly, daily por-
tions were individually packaged and stored at −80◦C in sealed containers to prevent lipid perox-
idation. All mice were fed a measured amount of fresh food each day, and food remaining in the 
cage was discarded. 
 
 
Tumor and Body Weight Measurements 
 
Lengths, widths, and depths of the subcutaneous tumors and body weights were measured 3 
times weekly using digital calipers (Fred W. Fowler Co., Newton, MA) and an electronic scale 
(Ohaus, Pinebrook, NJ), respectively. The instruments were connected to a laptop computer and 
all measurements were entered directly into an Excel spreadsheet by the instruments. The sub-
cutaneous, mid-scapular location of the tumor allowed a good estimate of the depth of the tumor. 
Tumor sizes were calculated using the formula for the volume of a prolate spheriod: V = 4/3 * 
3.14 * L/2 *W/2 * D/2. 
 
 
Necropsy and Tissue Processing 
 
Euthanasia was by isoflurane inhalation, then cervical dislocation. The tumor and liver were 
removed at necropsy. Portions of each tissue were fixed for histology, and the remaining portion 
was placed in an individually labeled vial and flash frozen in liquid nitrogen. At a later date, 
frozen livers or tumor were thawed and homogenized individually at 4◦C using a Polytron homo-
genizer (Brinkmann Kinematica Polytron from Fisher Scientific, IL) then divided into aliquots 
for subsequent analyses. 
 
 
Gas Chromatography (GC) 
 
The fatty acid compositions of cell membranes of liver and tumor were determined in 10 mice 
that consumed each diet. Samples were individually homogenized, and membranes were 
separated by ultracentrifugation. Chloroform:methanol was used for lipid extraction of each 
fraction; lipids were methylated and esterified in acetyl chloride-methanol as described (4). Gas 
chromatography was done using a Hewlett Packard 5890 Series 11 Gas Chromatograph (Palo 
Alto, CA) and conditions of: oven temperature ramp 1 at 150◦C for 15 min, ramp 2 at 175◦C for 
15 min, then ramp 3 at 225◦C for 7 min, injector temperature at 225◦C, flame-ionization detector 
at 250◦C, helium carrier gas at 42.3 psi. Fatty acid methyl ester standards (Nu-Chek-Prep, lysian, 
MN) were used for peak identification. The fatty acid methyl esters were reported as the percent 
of the total methylated fatty acids (area under the curve). 
 
 
Immunohistochemistry for PCNA and COX-2 
 
Immunohistochemical analyses for expression of proliferating cell nuclear antigen (PCNA) and 
cyclooxygenase 2 (COX-2) were performed on serial 4 μm thick histologic sections of the tumor. 
Standard immunohistochemical technique was employed using PC-10 (Biogenex, San Ramon, 
CA) as primary antibody for PCNA and PG27B (anti-PGHS 2, Oxford Biomedical Research, 
Oxford, MI) as primary antibody for COX-2. Secondary (anti-mouse or anti-rabbit IgG linked to 
biotin) and labeling (streptaviden-peroxidase) antibodies were from Biogenex (SuperSensitive 
Detection Kit, San Ramon, CA). Diaminobenzedine was used for the label. The number of 
PCNA positive cells in at least 500 cells in viable areas of 10 tumors were counted to determine 
the PCNA positive fraction of tumors from mice that consumed each diet. The presence of COX-
2 was assessed on a scale of 0 to 4 with 0 being absent and 4 being heavily staining for COX-2. 
An observer blinded to the diet group assessed 5 fields in viable areas of each tumor using a 40× 
objective. 
 
 
Statistical Analyses 
 
PRISMTM (GraphPad Software, San Diego, CA) software was used for statistical analyses. Tests 
for normality (basic statistics) were used on each data set. A t -test was used to determine 
statistically significant (P ≤ 0.05) differences in parametric parameters due to incorporation of 
corn or canola oil into the diet. A non-parametric Mann-Whitney test was used for differences in 
data (COX-2 expression) that did not meet the criteria for normality. PRISMTM was also used to 
generate a linear regression of linear portions (the latter half) of tumor growth and body weight 
curves. A t –test was used to test for differences between the slopes of the linear portions of the 
body weight and tumor growth curves. 
 
 
Results 
 
 
Effects due to increased omega 3 in the diet would not be expected to be seen until omega 3 fats 
had been incorporated into cell membrane phospholipids to be available for use as substrate for 
cell signaling molecules. Since the diet contained such a small amount of omega 3 fatty acid, it 
was expected that accumulation of significant amounts of EPA and DHA in the cell membranes 
would take 2 to 3 wk. Mouse weight and tumor growth rates began to diverge about 25 days 
after canola oil was incorporated into the diet of one group of mice. Thus day 25 was used as the 
cut point for calculation of effects of the diet on body weight and tumor growth. 
 
 
Fatty Acid Content of Diet and of Tissues 
 
Table 2. Polyunsaturated Fatty Acid Compositions of Oils Used in the Diets (% of total fatty acids) 
 
Corn Oil   Canola Oil 
______________________________________________________________________________ 
 
Linoleic acid (18-3:n-6)      57.00     21.00 
Alpha linolenic acid (18-3:n-6)       1.000    11.00 
Arachidonic acid (20-4:n-6)        0.080      0.16 
Eicosapentaenoic acid (20-5:n-3)       0.170      0.22 
Docosahexaenoic acid (22-6:n-3)       0.000      0.00 
______________________________________________________________________________ 
 
 
As expected, gas chromatography (Table 2) demonstrated that the fat in the diet contain-
ing 8% w/w corn oil was pre dominately omega 6 linoleic acid (57%) and that the corn oil diet 
contained only about 1% omega 3 fatty acids in the form of ALA. The fat in the diet containing 
8% w/w canola oil, however, contained 21% omega 6 linoleic acid and about 11% ALA. The n-6 
to n-3 ratio of the corn oil diet was 57:1 and of the canola oil diet was about 2:1. Neither the corn 
oil nor the canola oil contained appreciable amounts of either eicosapentaenoic (EPA) or docasa-
hexaenoic (DHA). The polyunsaturated fatty acid composition of the tumor and liver changed 
significantly due to the diet (Figs. 1A and 1B). The EPA and DHA (omega 3 fatty acids) content 
of both tumor and liver were significantly (P < 0.05) higher and linoleic and arachidonic acid 
(omega 6 fatty acids) were significantly (P < 0.05) lower in mice that consumed the canola oil 
diet than in mice that consumed the corn oil diet. Since the diet did not contain EPA or DHA, the 
source of the increased EPA and DHA in mice that consumed the canola oil diet must have been 
conversion from dietary ALA. 
 
 
Mouse Body Weights 
 
Figure 2 illustrates the mouse body weights. The mean body weights of the 2 groups of 
mice may began to diverge about day 12 but have certainly diverged by day 25. The initial body 
weights of the 2 groups of mice are not different, but at the end of the study, the final body 
weights were significantly different. The rates of gain for the last 32 days were also significantly 
different. The group that consumed canola oil continued to gain weight at about the same rate, 
0.06 ± 0.02 g/day (mean ± SD) as during the first 25 days. However, linear regression from day 
25 to day 57 indicated that the group that consumed the corn oil diet gained less weight. The rate 
of weight gain from day 25 to day 57 was 0.02 ± 0.02 g/day, a rate that was significantly 
(P<0.05) less than the rate of weight gain of the canola oil group. 
 
 
 
 
 
Growth Rate of the Tumors
The growth of the tumor was not expected to be altered until omega 3 dietary fatty acids 
(especially EPA and DHA) had accumulated in cell membranes. The tumor growth curves (Fig. 
3) show that perhaps by day 10 but certainly by day 25, the tumor growth rates of the 2 groups 
began to diverge indicating that sufficient omega 3 had accumulated for the tumor growth to be 
affected. The tumor growth rates for the first 25 days are not different and the complete tumor 
growth curves are obviously not linear if assessed from the first day of diet change until the end
of the experiment. However, the growth curve is approximately linear (see Fig. 3) from day 25
until the end of the experiment and linear regression of tumor growth from day 25 to day 57 (the
end of the experiment) was used to estimate the tumor growth rate. The mean ( ± SEM) tumor 
growth rate of the mice that consumed the corn oil diet was 7.5 ± 0.8 mm3/day, whereas the 
mean tumor growth rate of mice that consumed the canola oil diet was 3.2 ± 0.4 mm3/day. A t -
test of growth rates from day 25 to day 57 indicated that the mean growth rates of the two groups
were significantly different, P <0.001.
Figure 1. Fatty acid compositions of the tumor (A) and liver (B) of mice fed 
diets containing either 8% corn oil or 8% canola oil. The percent of the total
membrane fatty acids (means ± SEM) of major omega 6 (linoleic and arachidonic) 
and omega 3 (linolenic, eicosapentaenoic, and docosahexaenoic) fatty acids are shown. 
Error bars are given, but are so small that they may disappear into the top of the column.
Figure 2. Mean body weights (g ± SEM) of tumor bearing mice that
consumed diets containing 8% corn oil or 8% canola oil. Day 0 is the day
of diet change.
Proliferation and Tumor Volume
Proliferation was significantly (p = .0025) slower in tumors of the mice that consumed 
the canola oil diet. The PCNA positive fraction in viable areas of the tumors of mice that con-
sumed the corn oil diet was 8.8 ± 2.7% (mean % ± SD) and in the tumors of mice that consumed 
the canola oil diet the fraction was 4.1 ± 2.2%.
At the time of euthanasia, the mean volume of the tumors of the group that consumed
canola oil (126 mm3) was less than 1/2 the mean volume of the tumors of the group that con-
sumed corn oil (297 mm3). This was not quite significantly (p = 0.12) different. The time of 
euthanasia was determined by the time at which several mice in the corn oil fed group had 
Figure 3. Mean tumor volume (mm3) of mice that consumed diets containing 8% 
corn oil or 8% canola oil. Day 0 is the first day of the canola oil diet. The linear regression
lines superimposed on the data illustrate the mean growth rate of the tumors of each group 
from day 25 until the end of the study. The rates of growth of the tumors of the mice that 
consumed corn oil is significantly (P <0.05 by t -test of the slopes of the linear regressions)
greater than the rate of growth of the tumors of mice that consumed canola oil.
tumors so large that euthanasia was required. Given the large difference in tumor growth
rates and in tumor cell proliferation between the two groups, had the experiment been continued, 
the final volumes would have been significantly different.
Figure 4. The mean COX-2 stain intensities in viable areas of the tumor
were not significantly different due to the diet of the mice.
COX-2 in the Tumor
Long chain omega 3 fatty acids have been shown to suppress COX-2 expression in tumors. 
Immunohistochemistry was used for semi-quantitative assessment of the expression of COX-2 in 
the tumor (Fig. 4). A Mann-Whitney test showed that there was not a significant difference in the 
median stain due to the diet of the mice.
Discussion
The composition and amount of dietary fat has been shown to alter the tumor growth rate in
numerous animal studies (briefly reviewed in [1]). High amounts of dietary omega 6 fatty acids 
(especially linoleic acid) increase the growth rate of most tumor types compared to the growth 
rate of the tumor with lower amounts of omega 6 fatty acids in the diet. Consumption of long 
chain omega 3 fatty acids (i.e., fish oils containing EPA and DHA) has been shown to result in 
slower tumor growth than consumption of an equivalent amount of omega 6 fatty acids in the 
diet (5). Flaxseed at 10% w/w of the diet has been shown to slow growth of human breast
cancers in animal models (3). The fat composition of that diet was not reported. However the fat 
composition of that diet can be approximated since flaxseed contains 54% fat. Flaxseed oil 
contains about 55% ALA thus about 30% w/w of the flaxseed or about 3% w/w of that diet was 
ALA. In comparison about 0.8% of the test diet for this study was ALA. Humans do not 
consume 20% w/w of the diet as fish oil or as flaxseed, although a small amount of these sources 
of omega 3 fatty acids can be added to the diet. 
We hypothesized that a dietary change that humans might reasonably make, that of using 
canola oil instead of corn oil in the diet, would make a difference in the growth rate of cancers. 
We selected an 8% w/w corn oil diet as one that would include an amount of linoleic acid that is 
a more reasonable estimate for human linoleic acid consumption than found in the 20% w/w corn 
oil diets used in many previous experiments. A value that has been used for the average 
American diet is that 6.6% of energy is from LA (2). The corn oil diet in this study contained 
9.7% energy from LA, whereas the diet containing 20% w/w corn oil would derive about 24% of 
energy from linoleic acid. Substituting canola oil for the corn oil in the diet reduced the amount 
of LA and decreased the n-6 to n-3 ratio from about 57:1 to 2:1. To our knowledge, this is the 
first report indicating that substituting canola oil for the corn oil in the diet may have benefit for 
slowing the growth of cancers. 
We expected that the ALA of the canola oil would have to be elongated and desaturated 
to EPA and DHA before there would be any effect on tumor growth. There was almost no EPA 
or DHA in the dietary fat. The data indicate that the ALA in the canola oil was elongated and 
desaturated for incorporation into the membrane phospholipids as EPA and DHA since the fatty 
acid compositions of both tumor and liver of mice that consumed the canola oil diet contained 
significantly more EPA and DHA than did the tumor and liver of mice that consumed the corn 
oil diet. Surprisingly, ALA was slightly decreased in the tissues of the group that consumed  
canola oil. This may indicate that most ALA was being converted to EPA and DHA rather than 
being stored as ALA. As expected, the LA and AA acid content of the tumor and liver of the 
group that consumed canola oil was significantly less than that of the group that consumed 
canola oil. 
Consumption of long chain omega 3 fatty acids has been associated with decreased tumor 
associated cachexia (6–9). The graph of body weights (Fig. 2) indicates that the mean body 
weights of the 2 groups began to diverge about 25 days after the start of the dietary interventions. 
This is also about the same time as the tumor sizes began to diverge. Since tumors were larger in 
the group that consumed the corn oil containing diet, if the weight of the tumor had been sub-
tracted, the differences between the mean body weights of the two groups would have been even 
more pronounced. We hypothesize, but do not know, that body weight gain continued in the 
group that consumed canola oil because the tumor size was smaller and there was less production 
of cytokines related to cachexia (9–13). This is an area to be investigated in the future. 
Once omega 3 fatty acids were incorporated into the cell membranes of the mouse, the 
tumor growth rates began to diverge. During the second half of the project, the mean growth 
rate of the tumors of the mice that consumed canola oil was significantly less than the growth 
rate of the tumors of the mice that consumed corn oil. Our analyses of proliferation by PCNA 
immunohistochemistry indicated that a likely cause of the slower growth of the tumor was the 
decrease in tumor cell proliferation. The tumor volumes were not quite significantly different at 
the end of this study, however given the significant differences in growth rates and tumor cell 
proliferation, had the study continued for the longer time, the final tumor volumes would have 
been significantly different. Long chain omega 3 fatty acids have been shown to suppress 
proliferation in other studies (for example, [14]). 
The expression of COX-2was slightly but not significantly suppressed in the tumor as 
assessed by semi-quantitative analyses of immunohistochemical staining. The proliferation 
promoting eicosanoid, PGE2 is a product of COX-2 action on AA, whereas proliferation sup-
pressing PGE3 is a product of COX-2 action on EPA. Production of PGE2 or PGE3 could not be 
assessed in this study; however, one does wonder if the combination of reduced COX-2 activity 
and decreased AA would have significantly reduced the amount of PGE2 present in the tumor. 
SinceCOX-2 is at the beginning of a signaling cascade, further studies should be done to 
determine whether decreasedCOX-2 expression (even though not mathematically significant) 
could have biological significance for suppression of cytokines that promote cell proliferation. 
There are 2 sets of reports of potentially detrimental effects of canola oil consumption 
that must be acknowledged and weighed with the evidence in this report. One set involves 
feeding canola (rapeseed) oil to stroke-prone spontaneously hypertensive rats (15–19). In these 
reports, canola oil consumption has been associated with reduced lifespan of the rats. These rats 
have a deficiency in membrane cholesterol that makes red cell membranes weak and fragile (17). 
Thus, the rats are very sensitive to reduced dietary cholesterol and the phytosterols in canola oil 
can inhibit the absorption of dietary cholesterol (17). Increase consumption of phytosterols was 
associated with early death of the rats in two reports (15,17). The renal injury seen in one report 
(18) is also consistent with fragile cells. Reduced dietary cholesterol is not usually a problem in 
humans, and one author commented that there was no direct evidence that the effects in rats 
related to human nutrition (19). 
The other set of reports involves an increased risk for lung cancer among Chinese women 
who used unpurified canola oil (20–23) for stir frying. In these reports the increased risk was 
associated with excessive exposure to smoke from the high cooking temperatures. It is not clear 
if the carcinogens generated were from the meat being stir fried by generation of heterocyclic 
amines (22) or from carcinogens associated with the oil, though it was indicated that the risk 
seemed to increase with the use of canola oil, (21,23). It is unlikely that canola oil used in stir 
frying would effective suppress tumor growth, since the oil ingested would be highly oxidized 
and broken down to shorter chain fatty acids. 
 
 
Conclusions 
 
These data indicate that: 
 
1. Substituting canola oil for the corn oil in the diet can serve as a source of omega 3 fatty acids 
for suppression of tumor growth. The mechanisms for growth suppression were not identified 
and remain for further study. 
 
2. Gas chromatography indicated that the α-linolenic acid obtained from the canola oil was 
effectively converted to EPA and DHA for incorporation into tumor and host tissues. 
 
The importance of this study is that increasing the consumption of canola oil, a source of 
omega 3 fatty acids, and reducing the consumption of corn oil is a dietary change that could 
easily be incorporated into the Western diet. It has been proposed that omega 3 fatty acids may 
be effective cancer preventive agents (24). Especially in conjunction with increased fish con-
sumption, diet recommendations to include canola oil could reduce the risk for or slow the 
growth rate of cancer in future generations. 
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